Skip to main content
Premium Trial:

Request an Annual Quote

LGC Clinical Diagnostics Seraseq 22q11 Female-Matched Reference Material

LGC Clinical Diagnostics has launched its 22q11 Female-Matched Reference Material, part of the company's Seraseq noninvasive prenatal testing (NIPT) portfolio. The reference material can be used to develop a new test, validate an assay, monitor routine performance, troubleshoot problems across a workflow, and ensure overall proficiency. It is compatible with a broad range of NIPT assay methods, and uses a proprietary method that maintains native cell-free DNA characteristics such as a size profile of about 170 bp, size distribution, SNP content, and natural maternal-fetal size difference, LGC said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.